Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1983 1
1984 1
1987 2
1988 1
1989 1
1993 1
1996 2
1998 2
1999 2
2000 5
2001 2
2002 5
2003 3
2005 1
2006 2
2007 3
2008 2
2009 1
2010 3
2011 3
2012 9
2013 6
2014 9
2015 3
2016 7
2017 6
2018 9
2019 5
2020 6
2021 6
2022 6
2023 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 31643603

97 results

Results by year

Filters applied: . Clear all
Page 1
Melphalan.
[No authors listed] [No authors listed] 2020 Jan 15. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2020 Jan 15. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643603 Free Books & Documents. Review.
Busulfan.
[No authors listed] [No authors listed] 2017 Oct 2. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2017 Oct 2. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31644193 Free Books & Documents. Review.
Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study.
Cavo M, Gay F, Beksac M, Pantani L, Petrucci MT, Dimopoulos MA, Dozza L, van der Holt B, Zweegman S, Oliva S, van der Velden VHJ, Zamagni E, Palumbo GA, Patriarca F, Montefusco V, Galli M, Maisnar V, Gamberi B, Hansson M, Belotti A, Pour L, Ypma P, Grasso M, Croockewit A, Ballanti S, Offidani M, Vincelli ID, Zambello R, Liberati AM, Andersen NF, Broijl A, Troia R, Pascarella A, Benevolo G, Levin MD, Bos G, Ludwig H, Aquino S, Morelli AM, Wu KL, Boersma R, Hajek R, Durian M, von dem Borne PA, Caravita di Toritto T, Zander T, Driessen C, Specchia G, Waage A, Gimsing P, Mellqvist UH, van Marwijk Kooy M, Minnema M, Mandigers C, Cafro AM, Palmas A, Carvalho S, Spencer A, Boccadoro M, Sonneveld P. Cavo M, et al. Lancet Haematol. 2020 Jun;7(6):e456-e468. doi: 10.1016/S2352-3026(20)30099-5. Epub 2020 Apr 30. Lancet Haematol. 2020. PMID: 32359506 Clinical Trial.
Cyclophosphamide.
[No authors listed] [No authors listed] 2017 Nov 5. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2017 Nov 5. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643390 Free Books & Documents. Review.
A Phase IIb, Multicenter, Open-Label, Safety, and Efficacy Study of High-Dose, Propylene Glycol-Free Melphalan Hydrochloride for Injection (EVOMELA) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation.
Hari P, Aljitawi OS, Arce-Lara C, Nath R, Callander N, Bhat G, Allen LF, Stockerl-Goldstein K. Hari P, et al. Biol Blood Marrow Transplant. 2015 Dec;21(12):2100-2105. doi: 10.1016/j.bbmt.2015.08.026. Epub 2015 Aug 29. Biol Blood Marrow Transplant. 2015. PMID: 26327631 Free article. Clinical Trial.
Intravenous busulfan and melphalan as a conditioning regimen for autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: a matched comparison to a melphalan-only approach.
Blanes M, Lahuerta JJ, González JD, Ribas P, Solano C, Alegre A, Bladé J, San Miguel JF, Sanz MA, de la Rubia J. Blanes M, et al. Biol Blood Marrow Transplant. 2013 Jan;19(1):69-74. doi: 10.1016/j.bbmt.2012.08.009. Epub 2012 Aug 13. Biol Blood Marrow Transplant. 2013. PMID: 22897964 Free article. Clinical Trial.
Fifty years of melphalan use in hematopoietic stem cell transplantation.
Bayraktar UD, Bashir Q, Qazilbash M, Champlin RE, Ciurea SO. Bayraktar UD, et al. Biol Blood Marrow Transplant. 2013 Mar;19(3):344-56. doi: 10.1016/j.bbmt.2012.08.011. Epub 2012 Aug 24. Biol Blood Marrow Transplant. 2013. PMID: 22922522 Free PMC article. Review.
Cross-resistance to alkylating agents in multiple myeloma.
Bladé J, Feliú E, Rozman C, Estapé J, Millá A, Montserrat E. Bladé J, et al. Cancer. 1983 Sep 1;52(5):786-9. doi: 10.1002/1097-0142(19830901)52:5<786::aid-cncr2820520505>3.0.co;2-h. Cancer. 1983. PMID: 6871821
Evaluating the adverse effects of melphalan formulations.
Xiang E, Ni J, Glotzbecker B, Laubach J, Soiffer R, McDonnell AM. Xiang E, et al. J Oncol Pharm Pract. 2019 Oct;25(7):1631-1637. doi: 10.1177/1078155218804042. Epub 2018 Oct 18. J Oncol Pharm Pract. 2019. PMID: 30336728
97 results